D&Y Integrated Psychiatry provides evidence-based psychiatric evaluation and care for depression, anxiety, and mood instability related to the perimenopausal transition — in adults who deserve more than "this is just menopause."
The perimenopausal transition is a window of significantly elevated risk for new-onset depression and anxiety — and for meaningful worsening of existing mood conditions — driven by neurobiological changes in how the brain responds to hormonal fluctuation. D&Y provides thorough psychiatric evaluation that distinguishes perimenopausal depression from standard depression, from PMDD, and from other mood presentations, and builds a treatment plan that accounts for the hormonal context.
Perimenopause — the transitional period that begins years before menopause, often in the late 30s or 40s — involves significant fluctuations in estrogen and progesterone as ovarian function changes. These fluctuations affect serotonin, dopamine, and GABA neurotransmitter systems in ways that create genuine vulnerability to depression and anxiety. Women with a personal or family history of depression, PMDD, or mood sensitivity to hormonal shifts — postpartum mood changes, for example — are at particularly elevated risk.
Perimenopausal depression does not always look like the classic depression presentation. It frequently involves mood instability and irritability that is more prominent than flat affect, significant anxiety alongside low mood, sleep disruption that compounds everything, cognitive changes — difficulty concentrating, word-finding difficulties, brain fog — that are alarming in a high-functioning adult who has never experienced them before, and a loss of the emotional resilience that used to make stressors manageable.
The medical system frequently routes these patients to gynecology, where the conversation centers on HRT and symptom management rather than psychiatric evaluation. HRT can be a meaningful part of care for some patients — but it is not a psychiatric treatment, and it does not replace a proper evaluation of the mood condition itself. Women whose primary presentation is psychiatric need a psychiatric evaluation, not only a gynecological one.
For women with existing depression, anxiety, or bipolar spectrum conditions, perimenopause can represent a period of significant destabilization. A treatment plan that worked well for years may become inadequate — not because the underlying condition has changed, but because the hormonal context has shifted in ways that affect medication response and mood stability.
"Perimenopausal depression is frequently undertreated because it is framed as a hormonal issue rather than a mood disorder. These are not mutually exclusive — and both deserve proper clinical attention."— Denis Grigorov, PMHNP-BC · D&Y Integrated Psychiatry
A history of depression, anxiety, PMDD, or postpartum mood disorders significantly elevates risk for perimenopausal depression. The same hormonal sensitivity that drove those earlier presentations becomes relevant again during the perimenopausal transition.
Perimenopause is one of the most common windows for new-onset depression in women — even those with no prior history. The neurobiological changes are sufficient to trigger a clinical mood episode in women who have never experienced one before.
A psychiatric treatment plan that was stable for years may become inadequate during perimenopause. This is not treatment failure — it is a signal that the treatment plan needs to account for the changed hormonal context.
Our perimenopausal depression evaluation is a structured clinical interview that assesses the full mood history, the timing of symptom onset or worsening relative to the perimenopausal transition, the specific symptom constellation, and the full diagnostic picture — including whether a concurrent mood condition is present that requires independent management. He does not assume that hormonal change explains everything, and he does not dismiss the hormonal context as irrelevant.
Treatment at D&Y for perimenopausal depression follows the evidence for mood disorder treatment in this population. Your provider explains the mechanism of any recommended treatment, the expected timeline, and how the treatment will be evaluated at each follow-up. For patients who are also working with a gynecologist on HRT, D&Y coordinates to ensure the psychiatric and gynecological treatment plans are aligned rather than siloed. You will not be handed two separate care plans that have never spoken to each other.
The goal of treatment is restoration of the mood stability, cognitive functioning, and emotional resilience that the perimenopausal transition has disrupted — not just symptom reduction, but return to the functional baseline the patient knows is available to her. You have functioned well before. That is the target, not a vague improvement, but a return to yourself.
60–90 minutes. Your complete mood history is reviewed. Symptom onset is mapped against the perimenopausal timeline. A full differential is completed. Any existing treatment is evaluated for continued fit.
Your provider explains the clinical reasoning clearly. You receive a diagnosis that makes sense, a medication plan if indicated, and coordination with your gynecologist if HRT is part of the picture.
Mood and functional outcomes are tracked at every visit. Medication response is evaluated at structured intervals. Coordination with other providers is maintained as needed.
Ready to find out if perimenopausal depression is behind what you've been experiencing?
Book an AppointmentD&Y provides psychiatric evaluation and evidence-based treatment for perimenopausal depression and mood disorders in adults across California via telehealth. Book an Appointment to find out if the right evaluation can change how the next years look.
Book an AppointmentD&Y Integrated Psychiatry provides outpatient psychiatric care — not crisis services. If you need immediate support, the organizations below provide free, confidential help 24 hours a day. You do not need to be a D&Y patient to use any of these resources.
D&Y Integrated Psychiatry does not endorse or have a formal affiliation with the external organizations listed above. These resources are provided for informational purposes only. Listing does not constitute a referral or clinical recommendation.
